{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:00:09Z","timestamp":1787065209513,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204686"],"award-info":[{"award-number":["82204686"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e28467","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T22:27:49Z","timestamp":1710973669000},"page":"e28467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A UPLC-MS\/MS method for simultaneous determination of arachidonic acid, stearic acid, and related endocannabinoids in human plasma"],"prefix":"10.1016","volume":"10","author":[{"given":"Xiaojing","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangzhenzu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-5645","authenticated-orcid":false,"given":"Lingyun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2024.e28467_bib1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28467_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28467_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/1319-3767.114505","article-title":"The role of endocannabinoids system in fatty liver disease and therapeutic potentials","volume":"19","author":"Alswat","year":"2013","journal-title":"Saudi J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28467_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1208\/s12248-010-9178-0","article-title":"Role of cannabinoids in the development of fatty liver (steatosis)","volume":"12","author":"Purohit","year":"2010","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28467_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.35946\/arcr.v41.1.12","article-title":"Hepatic cannabinoid signaling in the regulation of alcohol-associated liver disease","volume":"41","author":"Yang","year":"2021","journal-title":"Alcohol Res"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28467_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00018-018-2994-6","article-title":"Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues","volume":"76","author":"Ruiz de Azua","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28467_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ijo.2015.179","article-title":"New insights on the role of the endocannabinoid system in the regulation of energy balance","volume":"40","author":"Gatta-Cherifi","year":"2016","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28467_bib8","doi-asserted-by":"crossref","first-page":"G655","DOI":"10.1152\/ajpgi.00294.2015","article-title":"Endocannabinoids in the gastrointestinal tract","volume":"311","author":"Lee","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e28467_bib9","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: a potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28467_bib10","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1172\/JCI83626","article-title":"Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages","volume":"127","author":"Ruiz de Azua","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28467_bib11","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/ijms21051554","article-title":"Obesity affects the Microbiota-Gut-Brain axis and the regulation thereof by endocannabinoids and related mediators","volume":"21","author":"Forte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28467_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.molmed.2011.05.002","article-title":"Energy balance regulation by endocannabinoids at central and peripheral levels","volume":"17","author":"Quarta","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e28467_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation","volume":"132","author":"Innes","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28467_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/ajcn\/nqz095","article-title":"Comparison of diets enriched in stearic, oleic, and palmitic acids on inflammation, immune response, cardiometabolic risk factors, and fecal bile acid concentrations in mildly hypercholesterolemic postmenopausal women-randomized crossover trial","volume":"110","author":"Meng","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28467_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2016.27","article-title":"Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects","volume":"6","author":"Ma","year":"2016","journal-title":"Nutr. Diabetes"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28467_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/biom10081133","article-title":"Arachidonic acid as an early indicator of inflammation during non-alcoholic fatty liver disease development","volume":"10","author":"Sztolsztener","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28467_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1745-7254.2007.00512.x","article-title":"Stearic acid protects primary cultured cortical neurons against oxidative stress","volume":"28","author":"Wang","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28467_bib18","first-page":"32","article-title":"Saturated and monounsaturated fatty acids increase interleukin-10 production in rat hepatocytes","volume":"42","author":"Nishitani","year":"2007","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28467_bib19","doi-asserted-by":"crossref","first-page":"G1101","DOI":"10.1152\/ajpgi.00057.2008","article-title":"Liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis","volume":"294","author":"Kunos","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28467_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.heliyon.2024.e28467_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114620","article-title":"Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS","volume":"211","author":"Yan","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28467_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000489032","article-title":"Determination of the endocannabinoids anandamide and 2-Arachidonoyl Glycerol with gas chromatography-mass spectrometry: analytical and preanalytical challenges and pitfalls","volume":"1","author":"Lanz","year":"2018","journal-title":"Med. Cannabis Cannabinoids"},{"key":"10.1016\/j.heliyon.2024.e28467_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.124392","article-title":"Determination of endocannabinoids and their conjugated congeners in the brain by means of muSPE combined with UHPLC-MS\/MS","volume":"257","author":"Fanti","year":"2023","journal-title":"Talanta"},{"key":"10.1016\/j.heliyon.2024.e28467_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jchromb.2014.11.001","article-title":"A quantitiative LC-MS\/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma","volume":"976\u2013977","author":"Gachet","year":"2015","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e28467_bib25","article-title":"Department of Health and human Services food and drug administration","year":"2018","journal-title":"guidance for industry; bioanalytical method validation"},{"key":"10.1016\/j.heliyon.2024.e28467_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpba.2018.12.036","article-title":"UPLC-MS\/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma","volume":"166","author":"Xu","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e28467_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.626897","article-title":"In vivo pharmacokinetic drug-drug interaction studies between fedratinib and antifungal agents based on a newly developed and validated UPLC\/MS-MS method","volume":"11","author":"Tang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28467_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12967-021-02820-7","article-title":"Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry","volume":"19","author":"Hu","year":"2021","journal-title":"J. Transl. Med."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e28467_bib29","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.3390\/ijms21217942","article-title":"The basal pharmacology of palmitoylethanolamide","volume":"21","author":"Rankin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e28467_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41232-018-0086-5","article-title":"Endocannabinoids and related N-acylethanolamines: biological activities and metabolism","volume":"38","author":"Tsuboi","year":"2018","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.heliyon.2024.e28467_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122252","article-title":"Simultaneous quantification of endocannabinoids, oleoylethanolamide and steroid hormones in human plasma and saliva","volume":"1152","author":"Ney","year":"2020","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28467_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1194\/jlr.M021378","article-title":"Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC\/MS\/MS","volume":"53","author":"Fanelli","year":"2012","journal-title":"J. Lipid Res."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e28467_bib33","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jchromb.2010.04.024","article-title":"Validation and application of an LC-MS\/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma","volume":"878","author":"Jian","year":"2010","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28467_bib34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1515\/CCLM.2006.065","article-title":"Release of anandamide from blood cells","volume":"44","author":"Vogeser","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.heliyon.2024.e28467_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jare.2017.11.004","article-title":"Arachidonic acid: physiological roles and potential health benefits - a review","volume":"11","author":"Tallima","year":"2018","journal-title":"J. Adv. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28467_bib36","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e28467_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413316","article-title":"New insights in the involvement of the endocannabinoid system and natural cannabinoids in nicotine dependence","volume":"22","author":"Saravia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28467_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/toxsci\/kfr081","article-title":"Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats","volume":"122","author":"Carr","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28467_bib39","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.23779","article-title":"Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration","volume":"52","author":"Teixeira-Clerc","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28467_bib40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol. Rev."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024044980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024044980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:08:04Z","timestamp":1784207284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024044980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024044980"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28467","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A UPLC-MS\/MS method for simultaneous determination of arachidonic acid, stearic acid, and related endocannabinoids in human plasma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28467"}}